BlueNord ASA
BlueNord ASA (0HTF.L) Financial Performance & Income Statement Overview
Explore the financials of BlueNord ASA (0HTF.L), including yearly and quarterly data on income, cash flow, and balance sheets.
BlueNord ASA (0HTF.L) Income Statement & Financial Overview
Analyze BlueNord ASA’s 0HTF.L earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $171.20M | $192.90M | $170.20M | $170.90M |
| Cost of Revenue | $122.70M | $112.20M | $110.90M | $121.50M |
| Gross Profit | $48.50M | $80.70M | $59.30M | $49.40M |
| Gross Profit Ratio | $0.28 | $0.42 | $0.35 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $13.20M | $11.80M | $8.80M | $8.70M |
| Total Costs & Expenses | $135.90M | $124.00M | $119.70M | $130.20M |
| Interest Income | $3.00M | $3.80M | $4.70M | $3.60M |
| Interest Expense | $38.90M | $39.90M | $42.30M | $25.30M |
| Depreciation & Amortization | $44.20M | $40.20M | $34.40M | $31.50M |
| EBITDA | $80.80M | $50.30M | $75.70M | $67.40M |
| EBITDA Ratio | $0.47 | $0.26 | $0.44 | $0.39 |
| Operating Income | $35.30M | $68.90M | $50.50M | $40.70M |
| Operating Income Ratio | $0.21 | $0.36 | $0.30 | $0.24 |
| Other Income/Expenses (Net) | -$37.60M | -$98.70M | -$51.50M | -$30.10M |
| Income Before Tax | -$2.30M | -$29.80M | -$1.00M | $10.60M |
| Income Before Tax Ratio | -$0.01 | -$0.15 | -$0.006 | $0.06 |
| Income Tax Expense | -$20.90M | $46.00M | -$12.00M | $11.90M |
| Net Income | $18.60M | -$75.90M | $11.00M | -$1.30M |
| Net Income Ratio | $0.11 | -$0.39 | $0.06 | -$0.008 |
| EPS | $0.70 | -$0.51 | $0.42 | -$0.05 |
| Diluted EPS | $0.40 | -$0.42 | $0.34 | -$0.05 |
| Weighted Avg Shares Outstanding | $26.50M | $26.50M | $26.49M | $26.18M |
| Weighted Avg Shares Outstanding (Diluted) | $31.30M | $32.02M | $32.02M | $26.18M |
Over the past four quarters, BlueNord ASA demonstrated steady revenue growth, increasing from $170.90M in Q2 2024 to $171.20M in Q1 2025. Operating income reached $35.30M in Q1 2025, maintaining a consistent 21% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $80.80M, reflecting operational efficiency. Net income rose to $18.60M, with EPS at $0.70. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan